FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2024
Back to search
Official data from USPTO
PHARMAVERSITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMAVERSITY
ST13
US500000079358754Class
41
Filing
79358754
Registration
7209722
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/04/2024
Trademark type
Word
Nice classes
41
Filing date
07/25/2022
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
11/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
LIU, PHILIP
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SCHOTT Pharma AG & Co. KGaA
S. A. (pessoa física)
Representatives
Ann K. Ford DLA Piper LLP (SU)
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educational servicesconducting on-line training seminars in the field of pharmaceutical packaging of glass and polymer
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2024
FIMP
FINAL DISPOSITION PROCESSED
02/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/07/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2023
PUBO
PUBLISHED FOR OPPOSITION
08/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2023
RFNT
REFUSAL PROCESSED BY IB
07/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/19/2023
RFRR
REFUSAL PROCESSED BY MPU
06/19/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/13/2023
CNRT
NON-FINAL ACTION WRITTEN
05/12/2023
DOCK
ASSIGNED TO EXAMINER
05/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/29/2022
Continuous trademark protection
Get notified about every new filing that threatens PHARMAVERSITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.